Restricted — LOI deadline passed
Atlas Opportunity Score 72/100
Verified October 6, 2026
Duke and UAB CFAR are accepting required letters of intent through October 1, 2026 for a two-institution HIV research pilot providing $50,000 per year for up to two years, split equally between the Duke and UAB MPIs. Full applications are due November 2, 2026; the controlling RFA does not state a submission time or time zone for either deadline.
Required next actionRequired LOI deadline passed October 1, 2026. The current full application deadline is November 2, 2026; refer to the Duke CFAR source for current cycle requirements and future updates.
Active - staged Solution Summary windows
Atlas Opportunity Score 72/100
4 days leftVerified October 3, 2026
The HHS Advanced Research Projects Agency for Health (ARPA-H) has opened the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) Innovative Solutions Opening, Notice ID ARPA-H-SOL-26-163. SPECTRA is a major autism precision-health research program intended to combine biological, clinical, developmental, environmental, family, behavioral, and real-world data to improve assessment, understand individual trajectories, and […]
Required next actionReview ARPA-H-SOL-26-163 and current SAM.gov attachments, select the applicable technical area, confirm proposer eligibility and a specific team contribution, and prepare the required Solution Summary within the applicable submission window. TA4 is due October 18, 2026 at 5:00 PM ET; TA1 and TA2 are due December 2, 2026 at 5:00 PM ET; TA3 is due January 18, 2027 at 5:00 PM ET.
Active
Atlas Opportunity Score 72/100
Verified September 15, 2026
Centers for Disease Control and Prevention (CDC)
The Centers for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities, is accepting applications for CDC-RFA-DD-26-0222, a cooperative agreement focused on long-term health outcomes for people living with spina bifida. Applications are due October 26, 2026 at 11:59 PM Eastern Time; an optional letter of intent is due September 26, […]
Required next actionEligible specialty clinics should verify current NSBPR or UMPIRE participation and every responsiveness criterion, review the September 17 CDC informational call or recording, and confirm required patient and visit thresholds, clinic or hospital commitment, and the Component B pediatric urology requirement before applying.
Active
Atlas Opportunity Score 72/100
Verified October 5, 2026
Idaho INBRE's Data Science Core Technology Access Grant supports eligible Idaho biomedical and behavioral researchers with up to $15,000 for access to advanced Data Science Core technologies and resources. The opportunity is open until further notice.
Required next actionConfirm investigator eligibility, project readiness, core-facility fit, current fund availability, and any required research approvals. Prepare a complete application aligned to the core-access scope and apply while funds remain available; projects able to generate grant or publication results within a year receive priority.
Active - LOI closed; invited full applications due December 11, 2026 at 5:00 PM PST
Atlas Opportunity Score 64/100
58 days leftVerified October 6, 2026
Washington National Biomedical Research Center (WaNBRC)
The 2027 WaNBRC Ignition Pilot Award LOI stage closed September 25, 2026. WaNBRC expects to notify selected LOI applicants on October 5; invited full applications are due December 11, 2026 at 5:00 PM PST. Two awards of up to $75,000 each are anticipated.
Required next actionMonitor the October 5, 2026 LOI decision. Invited applicants should finalize the WaNBRC-sponsored full proposal and submit it by December 11, 2026 at 5:00 PM PST; non-invited applicants should monitor a future cycle.
Active - Solution Summary stage
Atlas Opportunity Score 62/100
10 hours leftVerified October 6, 2026
HHS Advanced Research Projects Agency for Health (ARPA-H)
The HHS Advanced Research Projects Agency for Health (ARPA-H) is soliciting Solution Summaries for ASCENT-IBO, Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better Outcomes in Opioid Use Disorder. The initiative is intended to accelerate early-stage Phase 1 and Phase 2 clinical trials of ibogaine for people with opioid use disorder who are at […]
Required next actionReview ARPA-H-SN-26-158 and ARPA-H-SOL-24-106, verify all current amendments and clinical-regulatory requirements, and pursue only with a qualified clinical-trial team.
Active
Atlas Opportunity Score 58/100
Verified October 5, 2026
Idaho INBRE provides rolling supplementary support for biomedical research travel and seminar series. The next annual deadline is October 1, 2026; the FOA does not publish a clock time or time zone.
Required next actionKeep published as an ongoing recurring Idaho INBRE opportunity. The October 1, 2026 cycle has passed; prepare for the next recurring April 1, 2027 deadline, confirm current funding availability and Campus Leader coordination, and verify the proposed travel or seminar activity fits the published program rules before applying.
Active - Stage 2
Atlas Opportunity Score 58/100
Verified September 15, 2026
HHS Advanced Research Projects Agency for Health (ARPA-H)
The HHS Advanced Research Projects Agency for Health (ARPA-H) is soliciting qualified small businesses under its FY2026 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program, solicitation 7599226SN106. The current solicitation covers seven research topics spanning fertility diagnostics, versatile bioadhesives, a synthetic-biology toxin-removal platform, non-surgical endometriosis therapy, commercialization of technologies originating from […]
Required next actionVerify applicant-specific Stage 1 submission/encouragement, the controlling BAA cover page, topic fit, Stage 2 requirements, budget, registrations and submission instructions before pursuing. Do not treat this as a new-entry Stage 2 opportunity.
Active - Solution Summary stage
Atlas Opportunity Score 52/100
16 days leftVerified September 30, 2026
The HHS Advanced Research Projects Agency for Health (ARPA-H) has opened the UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening, Notice ID ARPA-H-SOL-26-162. UNIQUE seeks a new biomedical-imaging paradigm that combines anatomical, functional, molecular, and quantum-derived information so disease-related biological changes can be detected and interpreted earlier than with current imaging approaches. The program […]
Required next actionReview ARPA-H-SOL-26-162 and the current official materials, confirm the proposed team addresses the program's listed technical requirements, and submit the required Solution Summary by October 30, 2026 at 11:59 PM ET. The Full Proposal deadline is December 15, 2026 at 11:59 PM ET.
Active
Atlas Opportunity Score 50/100
Verified October 5, 2026
Idaho INBRE provides rolling support for eligible faculty to complete and submit INBRE related peer reviewed manuscripts. The current funding page identifies this opportunity as rolling.
Required next actionKeep published as a rolling Idaho INBRE opportunity. Confirm current availability, eligibility, manuscript progress requirements, journal plan, and budget before applying. No new fixed closing date or time is published on the current Idaho INBRE funding page.
Active for proposers that submitted the required Solution Summary by September 21, 2026 at 4:00 PM ET and advance; full proposals are due November 10, 2026 at 4:00 PM ET
Atlas Opportunity Score 50/100
Verified October 6, 2026
The HHS Advanced Research Projects Agency for Health (ARPA-H) is accepting submissions for the Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening, solicitation ARPA-H-SOL-26-160. FASTPASS is designed to create rapid, non-destructive tools that can verify pharmaceutical quality and safety through packaging at ports, warehouses, and other supply-chain nodes. The program has […]
Required next actionDo not treat FASTPASS as open to new proposers after the September 21 Solution Summary deadline. For teams that timely submitted the required Solution Summary and advance, review the current ARPA-H-SOL-26-160 solicitation and amendments and submit the full proposal through the ARPA-H Solutions process by November 10, 2026 at 4:00 PM ET.
Active - proposals open
Atlas Opportunity Score 48/100
Verified September 30, 2026
The HHS Advanced Research Projects Agency for Health (ARPA-H) has opened the Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening, Notice ID ARPA-H-SOL-26-165. COSMOS is designed to determine whether microgravity in low Earth orbit accelerates aging in human brain, heart, kidney, and uterine tissues and, if the effect is large enough, establish […]
Required next actionReview ARPA-H-SOL-26-165 and the current solicitation materials, confirm the proposed team meets the listed multidisciplinary requirements, and use the ARPA-H Solutions process for the October 7, 2026 at 2:00 PM ET proposal deadline.
Active - Solution Summary stage
Atlas Opportunity Score 38/100
Verified September 11, 2026
HHS Advanced Research Projects Agency for Health (ARPA-H)
The HHS Advanced Research Projects Agency for Health (ARPA-H) is accepting Solution Summaries for STREAM, Systems for Tracking and Resilience in Efficient Agricultural-input Management, through the Scalable Solutions Office Innovative Solutions Opening ARPA-H-SOL-24-105. STREAM is designed to reduce human exposure to herbicides while protecting agricultural productivity, food-system resilience, soil, and water. The program has four […]
Required next actionReview the current ARPA-H-SOL-24-105 solicitation and STREAM instructions before any submission-related action.
Active
Atlas Opportunity Score 24/100
Verified October 6, 2026
NIH/NIA plans one $2.5 million U24 cooperative agreement to coordinate and disseminate multimodal mouse brain data for aging and Alzheimer’s disease research. Applications are due November 10, 2026 at 5:00 PM local time.
Required next actionRelevant applicants should verify strong multimodal neuroscience data-management, integration, analytics, informatics, visualization, and dissemination capabilities and prepare for the November 10, 2026 submission deadline.
Closed — deadline passed
Verified September 18, 2026
Michigan Ovarian Cancer Alliance
Opportunity Overview The Michigan Ovarian Cancer Alliance (MIOCA) is accepting applications for the 2026 Geri Fournier Ovarian Cancer Research Grant. The program supports innovative ovarian cancer research conducted in Michigan by Michigan-based researchers. Proposals may be stand-alone projects or part of larger research efforts involving ovarian, peritoneal, or fallopian tube cancers. Funding and Deadline Individual […]
Required next actionClosed. The authoritative MIOCA announcement set the 2026 application deadline as September 18, 2026, which has passed. Do not begin or continue new applicant outreach, CRM production, or package execution for this cycle. Preserve the record for historical reference and monitor only for a future MIOCA research-grant cycle.
